VYNE Therapeutics Inc. (VYNE) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

VYNE Therapeutics Inc. (VYNE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $11.2M, listed on NASDAQ, employing roughly 13 people, carrying a beta of 2.00 to the broader market. VYNE Therapeutics Inc. Led by David T. Domzalski, public since 2018-01-25.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for VYNE as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →